geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis


, : Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis. Lancet. Diabetes & Endocrinology 3(4): 263-274

Results of several studies have shown a possible beneficial effect of renin-angiotensin system (RAS) inhibitors on diabetic retinopathy, but the findings were contradictory. We did a systematic review and meta-analysis to assess the effect of RAS inhibitors on diabetic retinopathy. We identified relevant publications in PubMed, Embase, Cochrane Library Central Register of Controlled Trials, and abstracts from main annual meetings. Only randomised controlled trials comparing angiotensin-converting enzyme (ACE) inhibitor or angiotensin-receptor blocker (ARB) monotherapy with other antihypertensive drugs or placebo in type 1 or type 2 diabetes were eligible for inclusion in the analysis. The primary outcomes were progression and regression of diabetic retinopathy in all patients and several subgroups. Risk ratios (RRs) with corresponding 95% CIs were pooled. We also did a network meta-analysis to assess the effect of different antihypertensive drugs on diabetic retinopathy by ranking order. This study is registered with the International Prospective Register of Systematic Reviews (PROSPERO), number CRD42013004548. 21 randomised clinical trials with 13,823 participants were included in the meta-analysis. RAS inhibitors were associated with reduced risk of progression (absolute risk difference -3%, 95% CI -5 to -1; pooled RR 0.87, 95% CI 0.80-0.95; p=0.002) and increased possibility of regression of diabetic retinopathy (8%, 1-16; RR 1.39, 95% CI 1.19-1.61; p=0.00002). In normotensive patients, RAS inhibitors decreased risk of diabetic retinopathy progression (0.81, 0.69-0.94; p=0.007) and increased possibility of regression (1.43, 1.14-1.79; p=0.002). In hypertensive patients, RAS inhibitors were not associated with difference in risk of progression of diabetic retinopathy (0.93, 0.79-1.10; p=0.42) or possibility of diabetic retinopathy regression (2.21, 0.92-5.31; p=0.08). ACE inhibitors were associated with reduced risk of diabetic retinopathy progression (0.84, 0.75-0.94; p=0.002) and higher possibility of disease regression (1.50, 1.20-1.86; p=0.0003). ARBs were associated with a higher possibility of diabetic retinopathy regression (1.32, 1.07-1.61; p=0.008), but had no effect on disease progression (0.92, 0.80-1.06; p=0.25). Network meta-analysis showed the association of antihypertensive drugs with risk of diabetic retinopathy progression was lowest for ACE inhibitors, followed by ARBs, β blockers, calcium channel blockers, and placebo in rank order. The association of antihypertensive drugs with possibility of diabetic retinopathy regression was highest for ACE inhibitors, followed by ARBs, placebo, and calcium channel blockers in rank order. In patients with diabetes, RAS inhibitors reduce the risk of diabetic retinopathy, and increase the possibility of diabetic retinopathy regression. ACE inhibitors might be better than ARBs for treating diabetic retinopathy, and might exert the most beneficial effect on diabetic retinopathy of all widely used antihypertensive drug classes.

US$19.90

PMID: 25660574

DOI: 10.1016/S2213-8587(14)70256-6


Other references

Witebsky Susan N.; Ehman Kenneth D., 1998: Structural and stratigraphic controls on contaminant migration in Miocene shallow marine sandy siltstones at the Stanford Linear Accelerator Center, Menlo Park, California. Contaminant migration in groundwater through fractured porous media is complex, and its characterization requires a detailed understanding of the site hydrogeologic system. As part of an ongoing remedial investigation at the Stanford Linear Accele...

Lang, Friederike, 2000: Acoustic communication distances of a gomphocerine grasshopper. I studied in the laboratory and in the field the communication distance of the gomphocerine grasshopper Chorthippus biguttulus, which lives close to the ground in stony, short grass habitats. Using sound measurements and behavioural tests, I exami...

Weiss G.H.; Mcatee N.; Mickley L.; Robertson C.N.; Gottesman M.M.; Pastan I.H.; Linehan W.M.; Fojo T., 1990: Clinical trial of amiodarone to suppress function of multidrug resistance gene product during chemotherapy for renal cell carcinoma. Journal of Urology 143(4 SUPPL): 385A

Madej, A.; Szymusik, I.; Oledzka, M.; Kosińska-Kaczyńska, K.; Bomba-Opoń, D.A.; Wielgoś, Mław., 2013: Evaluation of changes in the mode of twin deliveries over the years. The aim of the study was to evaluate changes in the course of twin deliveries over the years, with particular emphasis on the history of infertility duration of pregnancy mode of delivery indications for caesarean section (CS) and infant condition...

Schut, A.; Harrison, G.G.; Jenks, E., 1993: Beliefs and behaviors about infant care and feeding among Armenian immigrants in southern California. Clinical Research 41(1): 76A

Nowoslawski, A., 1963: Immunohistochemical Studies On The Presence And Distribution Of Serum Proteins In Foci Of Early Arteriosclerotic Changes In The Coronary Arteries. Rozprawy Wydzialu Nauk Medycznych 8: 137-171

Kong, C.Fong.; Bowtell, D., 2002: Genomewide gene expression analysis using cDNA microarrays. Methods in Molecular Medicine 68: 195-204

Messier, S.P.; Glasser, J.L.; Ettinger, W.H.; Craven, T.E.; Miller, M.E., 2002: Declines in strength and balance in older adults with chronic knee pain: a 30-month longitudinal, observational study. To document changes in lower extremity strength and balance over a 30-month period in older adults with chronic knee pain, and to identify relationships among these variables that may prove useful in designing a subsequent clinical intervention tr...

Heaton, D.W.lliam; Dines, S.; Dowell, R.I.n, 1999: High purity N- aminophenoscycarbonyl-L-glutamic acid. A new salt of a prodrug useful in antibody directed enzyme prodrug therapy (ADEPT) is disclosed. A hydrogen iodide salt of the prodrug N-(4-[N,N-bis(2-iodoethyl)amino]phenoxycarbonyl)-L-glutamic acid is prepared which can be obtained in crystallin...

Hugenholtz, H., 1994: The Canadian health care system in the nineties. Clinical Neurosurgery 41: 392-411